1. Home
  2. TMDX vs CATY Comparison

TMDX vs CATY Comparison

Compare TMDX & CATY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • CATY
  • Stock Information
  • Founded
  • TMDX 1998
  • CATY 1962
  • Country
  • TMDX United States
  • CATY United States
  • Employees
  • TMDX N/A
  • CATY N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CATY Major Banks
  • Sector
  • TMDX Health Care
  • CATY Finance
  • Exchange
  • TMDX Nasdaq
  • CATY Nasdaq
  • Market Cap
  • TMDX 2.3B
  • CATY 2.7B
  • IPO Year
  • TMDX 2019
  • CATY N/A
  • Fundamental
  • Price
  • TMDX $127.12
  • CATY $42.86
  • Analyst Decision
  • TMDX Buy
  • CATY Hold
  • Analyst Count
  • TMDX 10
  • CATY 5
  • Target Price
  • TMDX $122.89
  • CATY $49.80
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • CATY 322.0K
  • Earning Date
  • TMDX 05-08-2025
  • CATY 07-21-2025
  • Dividend Yield
  • TMDX N/A
  • CATY 3.17%
  • EPS Growth
  • TMDX N/A
  • CATY N/A
  • EPS
  • TMDX 1.41
  • CATY 3.95
  • Revenue
  • TMDX $488,227,000.00
  • CATY $691,279,000.00
  • Revenue This Year
  • TMDX $32.58
  • CATY $17.38
  • Revenue Next Year
  • TMDX $21.65
  • CATY $6.89
  • P/E Ratio
  • TMDX $90.23
  • CATY $10.85
  • Revenue Growth
  • TMDX 64.43
  • CATY N/A
  • 52 Week Low
  • TMDX $55.00
  • CATY $34.75
  • 52 Week High
  • TMDX $177.37
  • CATY $55.29
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 76.52
  • CATY 48.84
  • Support Level
  • TMDX $118.79
  • CATY $42.37
  • Resistance Level
  • TMDX $130.48
  • CATY $44.64
  • Average True Range (ATR)
  • TMDX 4.49
  • CATY 0.94
  • MACD
  • TMDX -0.15
  • CATY -0.19
  • Stochastic Oscillator
  • TMDX 83.53
  • CATY 27.04

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CATY Cathay General Bancorp

Cathay General Bancorp is a regional bank predominantly serving the Chinese-American community. The company's policy is to reach out and actively offer services to low-to-moderate income groups in the delineated branch service areas. It predominantly provides services such as checking and deposit, lines of credits, commercial and commercial real estate loans, merchant services and payment processing, treasury management services, international banking and financing services, and other customary banking services to individuals, professionals, and small to medium-sized businesses. Through its Wealth Management unit, the company also offers investment products and services, such as stocks, bonds, mutual funds, insurance, annuities and advisory services.

Share on Social Networks: